荷兰国家筛查规划中引入全国性早孕期异常扫描
荷兰于2021年11月至2022年12月开展全国性实施研究,在低危人群中开展早孕期异常扫描, uptake为74.9%(129704/173129),疑诊异常转诊率1.0%;对早孕期重大先天异常灵敏度84.6%(126/149),对全部异常灵敏度31.6%(537/1701),特异度99.2%(98055/98830)。
要点
- 低危人群早孕期异常扫描 uptake 为74.9%(129704/173129),疑诊异常转诊率为1.0%。
- 对早孕期重大先天异常灵敏度84.6%(126/149),对全部类型异常灵敏度31.6%(537/1701)。
- 结构异常确诊中位时间20天(6-43天),遗传学异常17天(8.5-27.5天)。
核心结论
- 新引入的全国性早孕期异常扫描在低危人群中显示对早孕期重大先天异常灵敏度高,对全部异常合计灵敏度较低。
- 该规划伴随1.0%的转诊率,其中59.1%为异常未确认或于24周前消退的病例。
- 转诊病例的确诊时间约在孕16周。
研究设计与样本
- 荷兰全国性实施研究,时间为2021年11月至2022年11月。
- 早孕期异常扫描于孕12+3至14+3周由认证超声医师按标准方案执行。
- 疑诊异常者转诊至三级诊疗中心。
- 评估指标包括 uptake、检测性能及转诊至最终产前诊断的时间。
主要发现
- 早孕期异常扫描 uptake 为74.9%(129704/173129)。
- 1.0%(1313/129704)疑诊异常,其中54.9%(721例)早孕期详细诊断扫描异常,44.6%(586例)结果正常,0.5%(6例)发生宫内胎儿死亡。
- 721例异常发现中,结构异常332例、遗传学异常117例、其他发现82例、一过性发现189例,1例转归未知。
- 早孕期异常扫描正常者中0.9%(1164例)于中孕期诊断胎儿异常。
- 对早孕期重大先天异常灵敏度84.6%(126/149),对全部类型异常灵敏度31.6%(537/1701);特异度99.2%(98055/98830),阳性预测值40.9%(537/1312),阴性预测值98.8%(98055/99219),阳性似然比40.3,阴性似然比0.7,假阳性率0.8%(775/98830),假阴性率68.4%(1164/1701)。
关键数值与推荐
- 早孕期重大先天异常灵敏度84.6%(126/149)。
- 全部类型异常灵敏度31.6%(537/1701),特异度99.2%(98055/98830)。
- 阳性预测值40.9%(537/1312),阴性预测值98.8%(98055/99219)。
- 阳性似然比40.3,阴性似然比0.7。
- 假阳性率0.8%(775/98830),假阴性率68.4%(1164/1701)。
临床怎么用
- 在低危人群中开展全国性早孕期异常扫描可检出早孕期重大先天异常,但对全部异常合计灵敏度较低。
- 疑诊异常转诊后,结构异常和遗传学异常的确诊中位时间分别为20天和17天。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A significant proportion of major fetal structural anomalies can be detected in the first trimester by ultrasound examination. However, the test performance of the first-trimester anomaly scan performed in a low-risk population as part of a nationwide prenatal screening program is unknown. Potential benefits of the first-trimester anomaly scan include early detection of fetal anomalies, providing parents with more time for reproductive decision-making. OBJECTIVE: To investigate the uptake, test performance, and time to a final prenatal diagnosis after referral. STUDY DESIGN: A nationwide implementation study was conducted in the Netherlands (November 2021-November 2022). The FTAS was performed between 12+3 and 14+3 weeks of gestation by certified sonographers using a standard protocol. Women were referred to a tertiary care center if anomalies were suspected. Uptake, test performance, and time to a final prenatal diagnosis (days between referral and date of final diagnosis/prognosis for reproductive decision-making) were determined. Test performance was calculated for first-trimester major congenital anomalies, such as anencephaly and holoprosencephaly and all diagnosed anomalies <24 weeks of gestation. RESULTS: The first-trimester anomaly scan uptake was 74.9% (129,704/173,129). In 1.0% (1313/129,704), an anomaly was suspected, of which 54.9% (n=721) had abnormal findings on the detailed first-trimester diagnostic scan and 44.6% (n=586) showed normal results. In 0.5% (n=6), intrauterine fetal death occurred. In the total group of 721 cases with abnormal findings, 332 structural anomalies, 117 genetic anomalies, 82 other findings (abnormal fetal biometry, sonomarkers, placental/umbilical cord anomaly, an-/oligohydramnios), and 189 cases with transient findings (defined as ultrasound findings which resolved <24 weeks of gestation) were found, with 1 case having an unknown outcome. 0.9% (n=1164) of all cases with a normal first-trimester anomaly scan were diagnosed with a fetal anomaly in the second trimester. Test performance included a sensitivity of 84.6% (126/149) for first-trimester major congenital anomalies and 31.6% (537/1701) for all types of anomalies. Specificity for all anomalies was 99.2% (98,055/98,830); positive predictive value 40.9% (537/1312); negative predictive value 98.8% (98,055/99,219); positive likelihood ratio 40.3; negative likelihood ratio 0.7; false positive rate 0.8% (775/98,830), and false negative rate 68.4% (1164/1701). The median time to diagnosis for structural anomalies was 20 days (6-43 days; median gestational age 16+3), for genetic anomalies 17 days (8.5-27.5 days; median gestational age 15+6 weeks), and for first-trimester major congenital anomalies 9 days (5-22 days; median gestational age 14+6 weeks). CONCLUSION: The performance of a newly introduced nationwide first-trimester anomaly scan in a low-risk population showed a high sensitivity for first-trimester major congenital anomalies and a lower sensitivity for all anomalies combined. The program was accompanied by a referral rate of 1.0%, of which 59.1% involved cases where anomalies were either not confirmed or resolved before 24 weeks gestation. Timing of diagnosis was around 16 weeks of gestation for referred cases. To evaluate the balance between benefits and potential harm of the first-trimester anomaly scan within a nationwide prenatal screening program, it is essential to assess the effectiveness of the program over time and to consider the perspectives of both women and their partners, as well as healthcare professionals.
引用
- Lust EER, Bronsgeest K, Henneman L, et al. Introduction of a nationwide first-trimester anomaly scan in the Dutch national screening program. Am J Obstet Gynecol. 2024. PMID: 39067498. doi:10.1016/j.ajog.2024.07.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。